1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Glioblastoma Research Program (GBMRP) is sponsored by Department of Defense (DOD) / Congressionally Directed Medical Research Programs (CDMRP). The Glioblastoma Research Program (GBMRP) is a stand-alone program created in FY24 to fund high-impact research specifically for glioblastoma, the most common and aggressive type of brain cancer. The CDMRP uses a community-driven process to identify and fund high-impact research.
Get alerted about grants like this
Get emailed when new opportunities from “Department of Defense (DOD) / Congressionally Directed Medical Research Programs (CDMRP)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Glioblastoma Research Program, Congressionally Directed Medical Research Programs You are using an outdated browser. Please upgrade your browser to improve your experience. U.S. Department of War organization.
Due to routine system maintenance the CDMRP website will be unavailable from COB 24 April - 27 April COB.
DEPARTMENT OF WAR - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS Transforming Health Care through Innovative and Impactful Research Vision – Improve glioblastoma patient survival and reduce adverse impact on Service Members, Veterans, their Families and the American public Mission – Promote rigorous, high-impact research to drive scientific discovery and advances in diagnosis, treatment and quality of life for patients with glioblastoma Click on image to view Program Summary Sheet According to the National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results, or SEERS, Program , glioblastoma affects three persons per 100,000 in the United States annually, making this cancer the most common type of brain cancer.
The NCI Center for Cancer Research reports that glioblastoma is highly aggressive with a median survival of 15-18 months while SEERS data demonstrates that only 6. 2% of patients survive five years post diagnosis. Studies continue to demonstrate a higher incidence of brain cancer among Service Members and the VA recently established brain cancers, including glioblastoma, as presumptive conditions associated with military service.
The Further Consolidated Appropriations Act 2024 provided $10 million for a Glioblastoma Research Program, or GBMRP, managed by the Congressionally Directed Medical Research Programs. The CDMRP previously funded research for glioblastoma through other research programs, the FY24 appropriation creates a stand-alone program to fund research for this type of brain cancer.
The CDMRP uses a community-driven process to identify and fund high-impact research. Consistent with CDMRP's program management processes, the GBMRP will solicit stakeholders for input on priority research areas for glioblastoma.
Representatives from across glioblastoma and related communities, such as academia, industry, military, Veteran, and other government and patient organizations, will have the opportunity to share perspectives on the major research and knowledge gaps in the field. Their input will help identify strategies for the new GBMRP and approaches with the greatest potential to improve glioblastoma patient outcomes.
FY24 GBMRP Stakeholders Meeting Summary and Gaps Congressional Appropriations Recent Applications Recommended for Funding FY24 Peer Review Participants FY24 GBMRP Recommended for Funding List Click here to provide feedback/comments to the GBMRP Last updated Monday, June 29, 2026
According to the current listing, eligibility includes: Representatives from academia, industry, military, Veteran, and other government and patient organizations. Confirm the full requirements in the official notice before applying.
Glioblastoma Research Program (GBMRP) is funded by Department of Defense (DOD) / Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Peer Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award is sponsored by Department of Defense (DOD) / Congressionally Directed Medical Research Programs (CDMRP). This award supports the translation of promising preclinical findings into products for clinical applications (prevention, detection, diagnosis, treatment, or quality of life) for diseases or conditions related to the FY26 PRMRP topic areas and strategic goals. Products can be tangible items or knowledge products. The program expects research to take an established proof-of-concept or prototype through final preclinical development, aiming for regulatory filing or translation into clinical practice. Products should also address the healthcare needs of military Service Members, Veterans, and their Families.
Tick-Borne Disease Research Program -- Therapeutic/Diagnostic Research Award is sponsored by Department of Defense (DOD) / Congressionally Directed Medical Research Programs (CDMRP). This award supports product-driven therapeutic and diagnostic development research aimed at reducing the burden of Lyme disease and/or other tick-borne diseases and conditions. Treatment-focused applications should be therapeutic evaluation studies designed to advance new ideas aimed at drug or treatment discovery that are still in the early/preclinical stages of development. Individuals in a mentored position are not considered independent investigators.
DoD Multidisciplinary Research Program of the University Research Initiative (MURI) is sponsored by Department of Defense (DoD) - Office of Naval Research (ONR). The Multidisciplinary Research Program of the University Research Initiative (MURI), administered by the Department of Defense Office of Naval Research, supports basic research in science and engineering at U. S.
SBIR SF254-D1206: Knowledge-Guided Test and Evaluation Frameworks for proliferated Low Earth Orbit Constellations is sponsored by U.S. Air Force. DOD SBIR topic SF254-D1206: Knowledge-Guided Test and Evaluation Frameworks for proliferated Low Earth Orbit Constellations. Component: U.S. Air Force. Command: SDA. Solicitation: DoD SBIR 2025.4. Phase(s): D2PII, II, SPII. Status: Pre-Release. Open date: 3/4/2026.
The Congressionally Directed Medical Research Programs just released $1.27 billion across 34 programs. Universities, nonprofits, and small businesses are all eligible.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read articleDoW's 2026 SBIR Broad Agency Announcement now operates on a monthly pre-release / quarterly close cadence. The 42 topics closing June 24 are the first test of whether the new rhythm produces the steady-state deal flow defense innovators have been asking for since 2022.
Read article